Tilray Brands Inc. (TLRY) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
655 MADISON AVENUE NEW YORK, NY 10065 |
| State of Incorp. | |
| Fiscal Year End | May 31 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 8/31/2024 MRQ | 5/31/2024 | 11/30/2023 MRQ | 5/31/2023 | 5/31/2022 | 5/31/2021 | 12/31/2020 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 260,522 | 259,791 | 448,529 | 415,909 | 488,466 | 189,702 | |||
| Cash and cash equivalents | 228,340 | 143,373 | 206,632 | 415,909 | 488,466 | 189,702 | |||
| Short-term investments | 32,182 | 116,418 | 241,897 | ||||||
| Restricted cash and investments | 1,576 | ||||||||
| Receivables | 101,695 | 90,596 | 86,227 | 95,279 | 87,309 | 41,155 | |||
| Inventory, net of allowances, customer advances and progress billings | 252,087 | 252,702 | 200,551 | 245,529 | 256,429 | 93,645 | |||
| Inventory | 252,087 | 252,702 | 200,551 | 245,529 | 256,429 | 93,645 | |||
| Prepaid expense | 31,012 | 6,542 | |||||||
| Asset, held-for-sale, not part of disposal group | 32,074 | ||||||||
| Deposits current assets | 15,976 | ||||||||
| Other current assets | 8,577 | ||||||||
| Other undisclosed current assets | 31,332 | 37,362 | 37,722 | 46,786 | 11,816 | ||||
| Total current assets: | 677,710 | 642,027 | 773,029 | 803,503 | 883,609 | 347,020 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 13,167 | ||||||||
| Operating lease, right-of-use asset | 16,101 | 13,551 | 5,941 | 12,996 | 18,267 | 17,985 | |||
| Property, plant and equipment | 429,667 | 587,499 | 199,559 | ||||||
| Long-term investments and receivables | 32,000 | 74,681 | 111,196 | 10,050 | 17,685 | 9,300 | |||
| Long-term investments | 7,795 | 10,050 | 17,685 | 9,300 | |||||
| Accounts and financing receivable, after allowance for credit loss | 32,000 | 74,681 | 103,401 | ||||||
| Intangible assets, net (including goodwill) | 2,924,353 | 2,963,133 | 2,982,628 | 3,919,180 | 4,438,712 | 353,360 | |||
| Goodwill | 2,008,884 | 2,009,714 | 2,008,843 | 2,641,305 | 2,832,794 | 166,915 | |||
| Intangible assets, net (excluding goodwill) | 915,469 | 953,419 | 973,785 | 1,277,875 | 1,605,918 | 186,445 | |||
| Other noncurrent assets | 5,395 | 9,406 | 222 | 314 | 8,285 | 4,356 | |||
| Other undisclosed noncurrent assets | 566,106 | 627,759 | 4,576 | 116,152 | 658,804 | 1,202 | |||
| Total noncurrent assets: | 3,543,955 | 3,688,530 | 3,534,230 | 4,646,191 | 5,141,753 | 598,929 | |||
| TOTAL ASSETS: | 4,221,665 | 4,330,557 | 4,307,259 | 5,449,694 | 6,025,362 | 945,949 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 241,957 | 216,898 | 190,682 | 157,431 | 212,813 | 55,803 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | ✕ | 6,772 | 148 | 3,473 | ||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 6,150 | 14,764 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 17,736 | 19,390 | 9,282 | ||
| Accounts payable | 105,392 | 88,363 | 70,819 | 68,604 | 57,706 | 17,776 | |||
| Accrued liabilities | 92,424 | 75,851 | 82,240 | 57,497 | 112,594 | 25,272 | |||
| Other undisclosed accounts payable and accrued liabilities | 44,141 | 52,684 | 37,623 | 672 | 8,211 | ||||
| Debt | 34,961 | 161,573 | 221,839 | 85,946 | 45,990 | ||||
| Derivative instruments and hedges, liabilities | 3,253 | 3,768 | 1,817 | ||||||
| Business combination, contingent consideration, liability | 15,000 | 7,704 | 16,218 | 16,007 | 60,657 | ||||
| Due to related parties | ✕ | ✕ | ✕ | 290 | |||||
| Other undisclosed current liabilities | 3,999 | 5,043 | 2,423 | 20,958 | 81,781 | 125,189 | |||
| Total current liabilities: | 299,170 | 394,986 | 432,979 | 280,342 | 401,241 | 181,282 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 331,883 | 292,790 | 357,933 | 129,208 | 221,432 | 336,882 | |||
| Long-term debt, excluding current maturities | 287,935 | 292,790 | 357,933 | 117,879 | 167,486 | 306,259 | |||
| Finance lease, liability | 43,948 | 35,481 | 15,277 | ||||||
| Liabilities, other than long-term debt | 147,434 | 179,454 | 178,468 | 196,829 | 269,752 | 53,886 | |||
| Deferred income tax liabilities | 130,870 | 166,454 | 167,364 | 196,638 | 265,845 | 49,274 | |||
| Other liabilities | 90 | 215 | 191 | 3,907 | 4,612 | ||||
| Operating lease, liability | 16,474 | 11,329 | 18,465 | 15,346 | |||||
| Business combination, contingent consideration, liability | 13,000 | 10,889 | |||||||
| Other undisclosed noncurrent liabilities | 69,974 | 7,936 | 401,949 | 667,624 | |||||
| Total noncurrent liabilities: | 479,317 | 542,218 | 544,337 | 727,986 | 1,158,808 | 390,768 | |||
| Total liabilities: | 778,487 | 937,204 | 977,316 | 1,008,328 | 1,560,049 | 572,050 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 3,442,906 | 3,368,337 | 3,315,692 | 4,398,805 | 4,459,070 | 373,899 | |||
| Common stock | 83 | 73 | 66 | 53 | 46 | ||||
| Additional paid in capital | 6,146,810 | 5,942,671 | 5,777,743 | 5,382,367 | 4,792,406 | 1,095,781 | |||
| Accumulated other comprehensive income (loss) | (43,499) | (38,367) | (46,610) | (20,764) | 152,668 | 8,205 | |||
| Accumulated deficit | (2,660,488) | (2,536,040) | (2,415,507) | (962,851) | (486,050) | (730,103) | |||
| Other undisclosed equity, attributable to parent | 16 | ||||||||
| Equity, attributable to noncontrolling interest | 272 | 25,016 | 14,251 | 42,561 | 6,243 | ||||
| Total equity: | 3,443,178 | 3,393,353 | 3,329,943 | 4,441,366 | 4,465,313 | 373,899 | |||
| TOTAL LIABILITIES AND EQUITY: | 4,221,665 | 4,330,557 | 4,307,259 | 5,449,694 | 6,025,362 | 945,949 | |||
Income Statement (P&L) ($ in thousands)
| 8/31/2024 TTM | 5/31/2024 | 11/30/2023 TTM | 5/31/2023 | 5/31/2022 | 5/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 788,942 | 516,309 | 627,124 | 628,372 | 513,085 | 191,339 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (565,591) | (436,403) | (480,164) | (511,555) | (389,903) | (185,827) | ||
| Other undisclosed gross profit | 19,143 | |||||||
| Gross profit: | 223,351 | 79,906 | 146,960 | 116,817 | 123,182 | 24,655 | ||
| Operating expenses | (398,096) | (1,362,763) | (1,516,645) | (727,218) | (255,353) | (219,796) | ||
| Other undisclosed operating loss | (5,983) | |||||||
| Operating loss: | (174,745) | (1,282,857) | (1,369,685) | (610,401) | (132,171) | (201,124) | ||
| Nonoperating income (expense) | (37,842) | (2,368) | (66,909) | 197,671 | (184,838) | 2,836 | ||
| Investment income, nonoperating | (20,708) | (11,312) | 1,812 | |||||
| Gain (loss), foreign currency transaction, before tax | (4,086) | (2,979) | (25,535) | (28,383) | (22,347) | 13,169 | ||
| Other nonoperating income (expense) | (37,842) | (3,189) | (66,909) | 5,208 | 8,015 | (10,333) | ||
| Interest and debt expense | (49,264) | (46,612) | (39,680) | (765) | 61,118 | |||
| Loss from continuing operations before equity method investments, income taxes: | (261,851) | (1,285,225) | (1,483,206) | (452,410) | (317,774) | (137,170) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 12,831 | (19,500) | 33,025 | 11,736 | (27,212) | (139,505) | ||
| Loss from continuing operations before income taxes: | (249,020) | (1,304,725) | (1,450,181) | (440,674) | (344,986) | (276,675) | ||
| Income tax expense (benefit) | 26,616 | 167 | 7,181 | 6,542 | 8,972 | 5,602 | ||
| Loss from continuing operations: | (222,404) | (1,304,558) | (1,443,000) | (434,132) | (336,014) | (271,073) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (434,132) | (336,014) | (271,073) | |
| Other undisclosed net income | 6,760 | |||||||
| Net loss: | (222,404) | (1,297,798) | (1,443,000) | (434,132) | (336,014) | (271,073) | ||
| Net income (loss) attributable to noncontrolling interest | (22,577) | 6,267 | (9,656) | (42,669) | (31,407) | |||
| Net loss available to common stockholders, diluted: | (244,981) | (1,291,531) | (1,452,656) | (476,801) | (367,421) | (271,073) | ||
Comprehensive Income ($ in thousands)
| 8/31/2024 TTM | 5/31/2024 | 11/30/2023 TTM | 5/31/2023 | 5/31/2022 | 5/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (222,404) | (1,297,798) | (1,443,000) | (434,132) | (336,014) | (271,073) | ||
| Other comprehensive income (loss) | 3,121 | 110,147 | (8,356) | (196,734) | 152,825 | |||
| Comprehensive loss: | (219,283) | (1,187,651) | (1,451,356) | (630,866) | (183,189) | (271,073) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (22,587) | (17,130) | (27,146) | (19,367) | (31,407) | |||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (1,514) | |||||||
| Comprehensive loss, net of tax, attributable to parent: | (241,870) | (1,204,781) | (1,478,502) | (650,233) | (214,596) | (272,587) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.